Overview

Single Dose Bioequivalence Study Comparing Nifedipine/Candesartan FDC (Fixed Dose Combination) With Loose Combination of Nifedipine GITS (Gastro-intestinal Therapeutic System) Plus Candesartan and Single Components Under Fasting Conditions

Status:
Completed

Trial end date:
2011-07-01

Target enrollment:

Participant gender:

Summary

Randomized, open label, single dose, 4-way crossover study to investigate the bioequivalence of a new fixed dose combination tablet of nifedipine GITS and candesartan with the corresponding loose combination and to compare it with the individual drugs

Phase:

Phase 1

Details

Lead Sponsor:

Bayer

Treatments:

Candesartan
Candesartan cilexetil
Nifedipine